Susquehanna International Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.5K | Buy |
+65,803
| New | +$39.5K | ﹤0.01% | 6066 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6986 |
|
|
2024
Q4 | – | Sell |
-41,730
| Closed | -$135K | – | 6714 |
|
|
2024
Q3 | $135K | Sell |
41,730
-26,406
| -39% | -$85.6K | ﹤0.01% | 4999 |
|
|
2024
Q2 | $204K | Buy |
68,136
+41,777
| +158% | +$125K | ﹤0.01% | 4711 |
|
|
2024
Q1 | $123K | Sell |
26,359
-16,866
| -39% | -$78.4K | ﹤0.01% | 4933 |
|
|
2023
Q4 | $179K | Buy |
43,225
+13,354
| +45% | +$55.3K | ﹤0.01% | 5068 |
|
|
2023
Q3 | $89.6K | Sell |
29,871
-31,431
| -51% | -$94.3K | ﹤0.01% | 4969 |
|
|
2023
Q2 | $151K | Sell |
61,302
-16,812
| -22% | -$41.4K | ﹤0.01% | 4801 |
|
|
2023
Q1 | $177K | Sell |
78,114
-78,281
| -50% | -$177K | ﹤0.01% | 4951 |
|
|
2022
Q4 | $546K | Buy |
156,395
+117,377
| +301% | +$410K | ﹤0.01% | 3086 |
|
|
2022
Q3 | $1.44M | Buy |
+39,018
| New | +$1.44M | ﹤0.01% | 2050 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6542 |
|
|
2022
Q1 | – | Sell |
-23,255
| Closed | -$524K | – | 6403 |
|
|
2021
Q4 | $524K | Sell |
23,255
-11,575
| -33% | -$261K | ﹤0.01% | 3729 |
|
|
2021
Q3 | $913K | Sell |
34,830
-33,231
| -49% | -$871K | ﹤0.01% | 2887 |
|
|
2021
Q2 | $2.18M | Buy |
68,061
+6,683
| +11% | +$214K | ﹤0.01% | 1980 |
|
|
2021
Q1 | $2.16M | Buy |
61,378
+49,622
| +422% | +$1.75M | ﹤0.01% | 2031 |
|
|
2020
Q4 | $377K | Buy |
+11,756
| New | +$377K | ﹤0.01% | 3686 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4892 |
|
|
2020
Q2 | – | Sell |
-83,566
| Closed | -$2.85M | – | 4805 |
|
|
2020
Q1 | $2.85M | Buy |
83,566
+65,967
| +375% | +$2.25M | ﹤0.01% | 1041 |
|
|
2019
Q4 | $686K | Buy |
+17,599
| New | +$686K | ﹤0.01% | 2280 |
|